Loading…

South Korean biopharmaceutical company Samyang Biopharm is investing HUF 8.6 billion (EUR 24.9 million) to build a medical equipment plant in Gödöllő, Hungary. The first phase will create 55 jobs.
“South Korean biopharmaceutical company Samyang Biopharm is investing HUF 8.6 billion (EUR 24.9m) to build a medical equipment plant in Gödöllő.”abouthungary.hu
Summarized from public sources; check the original articles before acting on it.